Selected abstract submissions will be presented during Oral Abstract Sessions generally lasting for 2 hours. Authors will present their peer-reviewed research in a specific topic area, and presentations will be moderated by experts in the field. A Scientific Overview may be included in an Oral Abstract Session, as appropriate, or a moderator may provide a brief translational summary at the close of a session. A comoderator will also be on hand to facilitate audience questions.
Updated for CROI 2018. Presentations from randomized trials and cohorts should follow the ICMJE guidelines, including reporting of study designs, (eg, prospective, observational, randomized, double-blind, STROBE, CONSORT, or others), statistical methods, and outcomes by demographic variables. See: ICMJE Preparing for Submission.
Of particular note, please consider whether there is substantive evidence of differences in effect by sex or other key demographic groups. If so, a stratified analysis should be made available during the presentation of the abstract at CROI. Please also note whether the study is ongoing or completed and whether the results are preliminary or final.
Oral presenters will be allocated 10 minutes for their presentation and 5 minutes for questions and answers with the audience. If the presentation exceeds 10 minutes, the moderator will interrupt, and the Q/A period will be shortened.
Our experience indicates that up to 10 slides is optimal, allowing 1 minute per slide. You may choose to use more than 10 slides, but please be sure to complete your presentation within the allocated 10 minutes. CROI will provide a title slide and a disclosure slide for each presenter based on the information that was submitted with the abstract. The content slides should give an overview of the research with conclusions and future research direction.
Please note that corporate logos, QR codes, and bar codes are not permitted on slides for oral presentations at CROI.
CROI will support MS PowerPoint or Apple Keynote only. Please ensure that all presentations are in one of these supported formats. High definition (HD) projectors will be used for all CROI sessions. Please apply widescreen formatting when preparing your slides (aspect ratio 16:9; resolution 1920 x 1080).
All presenters should bring their slides to the Speaker Ready Room at least 24 hours in advance of their presentation.
A slide that lists all financial relationships with commercial entities (eg, pharmaceutical and diagnostic companies, etc) will be prepared by CROI for each presenter. This disclosure slide will be based on the information submitted by the presenter during abstract submission. If a presenter does not have any financial relationships with commercial entities to disclose, the slide will read:
Dr. [insert presenting author’s name] has no financial relationships with commercial entities to disclose.
Samples of wording of financial disclosure slide:
- Sample 1: Dr [presenting author’s name] has served as a member of data monitoring committees for Company A [company name]–sponsored clinical trials.
- Sample 2: Dr [presenting author’s name] received research grants awarded to his institution from Company A [company name] and Company B [company name], has served as a consultant to Company C [company name], and owns stock in Company D [company name].
- Sample 3: Dr [presenting author’s name] is an employee of Company E [company name].